| Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics S Ghimire, MS Bolhuis, MGG Sturkenboom, OW Akkerman, ... European Respiratory Journal 47 (6), 1867-1869, 2016 | 85 | 2016 |
| Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment MS Bolhuis, OW Akkerman, MGG Sturkenboom, S Ghimire, S Srivastava, ... Clinical Infectious Diseases 67 (suppl_3), S327-S335, 2018 | 82 | 2018 |
| Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems AG Märtson, G Burch, S Ghimire, JWC Alffenaar, CA Peloquin Expert Opinion on Drug Metabolism & Toxicology 17 (1), 23-39, 2021 | 45 | 2021 |
| Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB S Ghimire, N Van't Boveneind-Vrubleuskaya, OW Akkerman, ... Journal of Antimicrobial Chemotherapy 71 (10), 2691-2703, 2016 | 43 | 2016 |
| Evaluation of saliva as a potential alternative sampling matrix for therapeutic drug monitoring of levofloxacin in patients with multidrug-resistant tuberculosis S Ghimire, B Maharjan, EM Jongedijk, JGW Kosterink, GR Ghimire, ... Antimicrobial Agents and Chemotherapy 63 (5), 10.1128/aac. 02379-18, 2019 | 40 | 2019 |
| Amikacin dosing for MDR tuberculosis: a systematic review to establish or revise the current recommended dose for tuberculosis treatment MGG Sturkenboom, N Simbar, OW Akkerman, S Ghimire, MS Bolhuis, ... Clinical Infectious Diseases 67 (suppl_3), S303-S307, 2018 | 36 | 2018 |
| Emerging drugs and alternative possibilities in the treatment of tuberculosis S Hofman, MM Segers, S Ghimire, MS Bolhuis, MGG Sturkenboom, ... Expert opinion on emerging drugs 21 (1), 103-116, 2016 | 28 | 2016 |
| Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs J Kuhlin, MGG Sturkenboom, S Ghimire, I Margineanu, ... Clinical Mass Spectrometry 14, 34-45, 2019 | 22 | 2019 |
| Rat precision-cut liver slices predict drug-induced cholestatic injury V Starokozhko, R Greupink, P van de Broek, N Soliman, S Ghimire, ... Archives of toxicology 91, 3403-3413, 2017 | 22 | 2017 |
| Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin SHJ van den Elsen, OW Akkerman, EM Jongedijk, M Wessels, S Ghimire, ... European Respiratory Journal 55 (5), 2020 | 21 | 2020 |
| Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients S Ghimire, B Maharjan, EM Jongedijk, JGW Kosterink, GR Ghimire, ... European Respiratory Journal 53 (4), 2019 | 21 | 2019 |
| Determination of levofloxacin in human serum using liquid chromatography tandem mass spectrometry S Ghimire, K van Hateren, N Vrubleuskaya, R Koster, D Touw, ... Journal of Applied Bioanalysis 4 (1), 16-25, 2018 | 19 | 2018 |
| Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid SHJ van den Elsen, OW Akkerman, M Wessels, EM Jongedijk, S Ghimire, ... European Respiratory Journal 56 (4), 2020 | 14 | 2020 |
| Pharmacokinetics of 2,000 milligram ertapenem in tuberculosis patients MA Zuur, S Ghimire, MS Bolhuis, AMA Wessels, R van Altena, ... Antimicrobial Agents and Chemotherapy 62 (5), 10.1128/aac. 02250-17, 2018 | 11 | 2018 |
| Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care S Ghimire, D Iskandar, R van der Borg-Boekhout, M Zenina, MS Bolhuis, ... European Respiratory Journal 60 (6), 2022 | 10 | 2022 |
| Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study S Ghimire, S Karki, B Maharjan, JGW Kosterink, DJ Touw, ... BMJ open respiratory research 7 (1), e000606, 2020 | 8 | 2020 |
| Direct oral anticoagulants for disseminated intravascular coagulation: an alliterative wordplay or potentially Valuable Therapeutic interventions? G Lippi, F Langer, EJ Favaloro Seminars in thrombosis and hemostasis 46 (04), 457-464, 2020 | 7 | 2020 |
| Safety of rifampicin at high dose for difficult-to-treat tuberculosis: protocol for RIAlta Phase 2b/c Trial J Espinosa-Pereiro, S Ghimire, MGG Sturkenboom, JWC Alffenaar, ... Pharmaceutics 15 (1), 9, 2022 | 5 | 2022 |
| Cross-validation of Liquid Chromatography-Tandem Mass Spectrometry method for quantification of Levofloxacin in saliva S Ghimire, EM Jongedijk, SHJ van den Elsen, MA Wessels, DJ Touw, ... Journal of Applied Bioanalysis 6 (2), 68-70, 2020 | 5 | 2020 |
| Understanding the pharmacokinetics of antibiotics in pregnancy: Is there a role for therapeutic drug monitoring? A narrative review J Stojanova, M Arancibia, S Ghimire, I Sandaradura Therapeutic Drug Monitoring 44 (1), 50-64, 2022 | 4 | 2022 |
